Hostname: page-component-78c5997874-t5tsf Total loading time: 0 Render date: 2024-11-14T04:26:30.185Z Has data issue: false hasContentIssue false
  • English
  • Français

A prospective study of exposure to verotoxin-producing Escherichia coli among Canadian children with haemolytic uraemic syndrome

Published online by Cambridge University Press:  15 May 2009

P. C. Rowe ,
E. Orrbine ,
H. Lior ,
G. A. Wells  and
P. N. McLaine
P. C. Rowe
Affiliation:
Canadian Pediatric Kidney Disease Reference Centre, Ottawa, and theNational Laboratory for Enteric Pathogens, Laboratory Centre for Disease Control, Ottawa, Canada
E. Orrbine
Affiliation:
Canadian Pediatric Kidney Disease Reference Centre, Ottawa, and theNational Laboratory for Enteric Pathogens, Laboratory Centre for Disease Control, Ottawa, Canada
H. Lior
Affiliation:
Canadian Pediatric Kidney Disease Reference Centre, Ottawa, and theNational Laboratory for Enteric Pathogens, Laboratory Centre for Disease Control, Ottawa, Canada
G. A. Wells
Affiliation:
Canadian Pediatric Kidney Disease Reference Centre, Ottawa, and theNational Laboratory for Enteric Pathogens, Laboratory Centre for Disease Control, Ottawa, Canada
P. N. McLaine*
Affiliation:
Canadian Pediatric Kidney Disease Reference Centre, Ottawa, and theNational Laboratory for Enteric Pathogens, Laboratory Centre for Disease Control, Ottawa, Canada
*
*Dr Peter N. McLaine, Director, Canadian Pediatric Kidney Disease Reference Centre, 401 Smyth Road, Ottawa, Ontario, Canada K1H 8L1.
Rights & Permissions [Opens in a new window]

Summary

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Haemolytic uraemic syndrome (HUS) is a leading cause of acute renal failure in childhood. Although infection with Escherichia coli O 157. H7 has been associated with HUS in North America and Europe, only a limited number of studies have examined the role of other verotoxin-producing E. coli (VTEC) serotypes in this condition. To address this issue, we conducted a comprehensive, prospective microbiological study of patients treated for HUS at eight Canadian hospitals in the summer of 1990. Of the 34 consecutive patients with HUS enrolled over 4 months, E. coli 0 157. H7 was isolated from the stools of 26, and other E. coli serotypes were isolated from four patients. In four subjects no pathogenic E. coli serotypes were identified on stool culture. Using oligonucleotide probes specific for VT-1 and VT-2, verotoxin genes were detected in the stool isolates of all patients with E. coli O 157.H7, and from two with other E. coli serotypes. Two other patients had at least a fourfold rise in anti-verotoxin antibodies. Strong evidence of exposure to a verotoxin was present in 30/34 (88%). Patients with E. coli 0 157.H7 infection were more likely to develop an antibody response to VT-2 than to VT-1 (22/22 vs 12/22; P = 0.002). These results further strengthen the association of HUS with verotoxin-producing E. coli in North America, and confirm that E. coli serotypes other than 0 157. H7 are isolated in a small proportion of summertime HUS episodes.

Type
Research Article
Information
Epidemiology & Infection , Volume 110 , Issue 1 , February 1993 , pp. 1 - 7
Copyright
Copyright © Cambridge University Press 1993

References

REFERENCES

1.Levin, M, Walters, MDS, Barratt, TM. Hemolytic uremic syndrome. Adv Pediatr Infect Dis 1989; 4: 51–82.Google Scholar
2.Rowe, PC, Orrbine, E, Wells, GA, McLaine, PN. Epidemiology of hemolytic uremic syndrome in Canadian children from 1986 to 1988. J Pediatr 1991; 119: 218–24.Google Scholar
3.Karmali, MA, Petric, M, Steele, BT, Lim, C. Sporadic cases of haemolytic-uremic syndrome associated with faecal cytotoxin-producing Escherichia coli in stools. Lancet 1983; i: 619–20.CrossRefGoogle Scholar
4.Tarr, PI, Neill, MA, Clausen, CR, Watkins, SL, Christie, DL, Hickman, RO. Escherichia coli O 157. H7 and the hemolytic uremic syndrome: importance of early cultures in establishing the etiology. J Infect Dis 1990; 162: 553–6.Google Scholar
5.Grandsen, WR, Damm, MAS, Anderson, JD, Carter, JE, Lior, H. Further evidence associating hemolytic uremic syndrome with infection by verotoxin-producing Escherichia coli O 157. H7. J Infect Dis 1986; 154: 522–4.Google Scholar
6.Kleanthous, H, Smith, HR, Scotland, SM, et al. Haemolytic uraemic syndromes in the British biological aspects. Arch Dis Child 1990; 65: 722–7.Google Scholar
7.Bitzan, M, Moebius, E, Ludwig, K, Muller-Wiefel, DE, Heesemann, J, Karch, H. High incidence of serum antibodies to Escherichia coli O 157 lipopolysaccharide in children with hemolytic-uremic syndrome. J Pediatr 1991; 119: 380–5.Google Scholar
8.Karmali, MA, Petric, M, Lim, C, Fleming, PC, Arbus, GS, Lior, H. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis 1985; 151: 775–82.Google Scholar
9.Chart, H, Smith, HR, Scotland, SM, Rowe, B, Milford, DV, Taylor, CM. Serologic identification of Escherichia coli O 157. H7 infection in haemolytic uraemic syndrome. Lancet 1991; 337: 138–40.Google Scholar
10.Chart, H, Rowe, B. Serological identification of infection by Vero cytotoxin-producing Escherichia coli in patients with haemolytic uraemic syndrome. Serodiag Immunother Infect Dis 1990; 4: 413–18.Google Scholar
11.Rogers, MF, Rutherford, GW, Alexander, SR. et al. A population-based study of hemolytic-uremic syndrome in Oregon. 1979–1982. Am J Epidem 1986; 123: 137–42.Google Scholar
12.Milford, DV, Taylor, CM, Guttridge, B, Hall, SM, Rowe, B, Kleanthous, H. Haemolytic uraemic syndromes in the British Isles, 1985–8: association with verocytotoxin-producing Escherichia coli. Part 1. Clinical and epidemiological aspects. Arch Dis Child 1990; 65: 716–21.Google Scholar
13.March, SB. Ratnam, S. Sorbitol-MacConkey medium for detection of Escherichia coli O 157.H7 associated with hemorrhagic colitis. J Clin Microbiol 1986; 23: 869–72.CrossRefGoogle Scholar
14.Pollard, DR. Johnson, WM, Lior, H, Tyler, SD, Rozee, KR. Rapid and specific detection of verotoxin genes in Escherichia coli by the polymerase chain reaction. J Clin Microbiol 1990; 28: 540–5.Google Scholar
15.Perera, LP, Marques, LRM, O'Brien, AD. Isolation and characterization of monoclonal antibodies to Shiga-like toxin II of enterohemorrhagic Escherichia coli and use of monoclonal antibodies in a colony enzyme-linked immunosorbent assay. J Clin Microbiol 1988; 26: 2127–31.Google Scholar
16.Konowalchuk, J, Speirs, JI, Stavrie, S. Vero response to a cytotoxin of Escherichia coli. Infect Immun 1977; 18: 775–9.Google Scholar
17.Levine, MM, Xu, J, Kaper, JB, et al. A DNA probe to identify enterohemorrhagic Escherichia coli of O 157. H7 and other serotypes that cause hemorrhagic colitis and hemolytic uremic syndrome. J Infect Dis 1987; 156: 175–82.Google Scholar
18.Karmali, MA. Infection by verotoxin-producing Escherichia coli. Clin Microbiol Rev 1989; 2: 15–38.CrossRefGoogle Scholar
19.Lopez, EL, Diaz, M, Grinstein, S. et al. Hemolytic uremic syndrome and diarrhea in Argentine children: the role of Shiga-like toxins. J Infect Dis 1989; 160: 469–75.Google Scholar
20.Scotland, SM, Willishaw, GA, Smith, HR, Rowe, B. Properties of strains of Escherichia coli belonging to serogroup O 157 with special reference to production of Vero cytotoxins VT 1 and VT 2. Epidemiol Infect 1987; 99: 613–24.Google Scholar
21.Ostroff, SM, Tarr, PI. Neill, MA, Lewis, JH, Hargrett-Bean, N, Kobayashi, JM. Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli O 157.H7 infections. J Infect Dis 1989; 160: 994–8.Google Scholar
22.Obrig, TG, Del, Vecchio PJ, Brown, JE. et al. Direct cytotoxic action of shiga toxin on human vascular endothelial cells. Infect Immun 1988; 56: 2373–8.Google Scholar
23.Tesh, VL, Samuel, JE, Perera, LP, Sharefkin, JB, O'Brien, AD. Evaluation of the role of Shiga and Shiga-like toxins in mediating direct damage to human vascular endothelial cells. J Infect Dis 1991; 164: 344–52.CrossRefGoogle ScholarPubMed
24.Kaplan, BS, Cleary, TG, Obrig, TG. Recent advances in understanding the pathogenesis of the hemolytic uremic syndromes. Pediatr Nephrol 1990; 4: 276–83.Google Scholar